IL-4 acts as a myoblast recruitment factor during mammalian muscle growth

Cell

Volumn 113, Issue 4, 2003, Pages 483-494

  Horsley, Valerie ^a,b   Jansen, Katie M ^a   Mills, Stephen T ^b   Pavlath, Grace K ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; NUCLEAR FACTOR; PROTEIN SUBUNIT;

ANIMAL CELL; ARTICLE; CELL FUSION; CELL GROWTH; CONTROLLED STUDY; GENE CONTROL; MAMMAL; MOLECULAR DYNAMICS; MOUSE; MUSCLE GROWTH; MYOBLAST; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALIA; MAMMALIA;

EID: 0037726553     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00319-2     Document Type: Article

References (44)

1. Abbott K.L., Friday B.B., Thaloor D., Murphy T.J., Pavlath G.K. Activation and cellular localization of the cyclosporine A-sensitive transcription factor NF-AT in skeletal muscle cells. Mol. Biol. Cell. 9:1998;2905-2916.
2. Allen D.L., Roy R.R., Edgerton V.R. Myonuclear domains in muscle adaptation and disease. Muscle Nerve. 22:1999;1350-1360.
3. Barks J.L., McQuillan J.J., Iademarco M.F. TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J. Immunol. 159:1997;4532-4538.
4. Barnoy S., Glasner T., Kosower N.S. The role of calpastatin (the specific calpain inhibitor) in myoblast differentiation and fusion. Biochem. Biophys. Res. Commun. 220:1996;933-938.
5. Blau H.M., Springer M.L. Muscle-mediated gene therapy. N. Engl. J. Med. 333:1995;1554-1556.
6. Constantin B., Cognard C., Raymond G. Myoblast fusion requires cytosolic calcium elevation but not activation of voltage-dependent calcium channels. Cell Calcium. 19:1996;365-374.
7. Crabtree G.R., Olson E.N. NFAT signaling. choreographing the social lives of cells Cell. 109:2002;S67-S79.
8. Darr K.C., Schultz E. Hindlimb suspension suppresses muscle growth and satellite cell proliferation. J. Appl. Physiol. 67:1989;1827-1834.
9. DeFife K.M., Jenney C.R., McNally A.K., Colton E., Anderson J.M. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 158:1997;3385-3390.
10. Delling U., Tureckova J., Lim H.W., De Windt L.J., Rotwein P., Molkentin J.D. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol. Cell. Biol. 20:2000;6600-6611.
11. Doering J.L., Fischman D.A. A fusion-promoting macromolecular factor in muscle conditioned medium. Exp. Cell Res. 105:1977;437-443.
12. Donaldson D.D., Whitters M.J., Fitz L.J., Neben T.Y., Finnerty H., Henderson S.L., O'Hara R.M. Jr., Beier D.R., Turner K.J., Wood C.R., Collins M. The murine IL-13 receptor alpha 2. molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1 J. Immunol. 161:1998;2317-2324.
13. Gorza L., Vitadello M. Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence. FASEB J. 14:2000;461-475.
14. Harris A.J., Duxson M.J., Fitzsimons R.B., Rieger F. Myonuclear birthdates distinguish the origins of primary and secondary myotubes in embryonic mammalian skeletal muscles. Development. 107:1989;771-784.
15. Hodge M.R., Ranger A.M., Charles de la Brousse F., Hoey T., Grusby M.J., Glimcher L.H. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity. 4:1996;397-405.
16. Horsley V., Friday B.B., Matteson S., Kegley K.M., Gephart J., Pavlath G.K. Regulation of the growth of multinucleated muscle cells by an NFATC2-dependent pathway. J. Cell Biol. 153:2001;329-338.
17. Huerta L., Lamoyi E., Baez-Saldana A., Larralde C. Human immunodeficiency virus envelope-dependent cell-cell fusion. a quantitative fluorescence cytometric assay Cytometry. 47:2002;100-106.
18. Kitazawa S., Ross F.P., McHugh K., Teitelbaum S.L. Interleukin-4 induces expression of the integrin alpha v beta 3 via transactivation of the beta 3 gene. J. Biol. Chem. 270:1995;4115-4120.
19. Konigsberg I.R. Diffusion-mediated control of myoblast fusion. Dev. Biol. 26:1971;133-152.
20. Lind M., Deleuran B., Yssel H., Fink-Eriksen E., Thestrup-Pedersen K. IL-4 and IL-13, but not IL-10, are chemotactic factors for human osteoblasts. Cytokine. 7:1995;78-82.
21. Marino M., Scuderi F., Mazzarelli P., Mannella F., Provenzano C., Bartoccioni E. Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts. J. Neuroimmunol. 116:2001;94-101.
22. McInnes A., Rennick D.M. Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J. Exp. Med. 167:1988;598-611.
23. McNally A.K., Anderson J.M. Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am. J. Pathol. 160:2002;621-630.
24. Mitchell P.O., Pavlath G.K. A muscle precursor cell-dependent pathway contributes to muscle growth after atrophy. Am. J. Physiol. Cell Physiol. 281:2001;C1706-C1715.
25. Monticelli S., Rao A. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur. J. Immunol. 32:2002;2971-2978.
26. Murata T., Taguchi J., Puri R.K. Interleukin-13 receptor alpha' but not alpha chain. a functional component of interleukin-4 receptors Blood. 91:1998;3884-3891.
27. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor. signaling mechanisms and biologic functions Annu. Rev. Immunol. 17:1999;701-738.
28. Pavlath G.K., Thaloor D., Rando T.A., Cheong M., English A.W., Zheng B. Heterogeneity among muscle precursor cells in adult skeletal muscles with differing regenerative capacities. Dev. Dyn. 212:1998;495-508.
29. Phelan J.N., Gonyea W.J. Effect of radiation on satellite cell activity and protein expression in overloaded mammalian skeletal muscle. Anat. Rec. 247:1997;179-188.
30. Rahaman S.O., Sharma P., Harbor P.C., Aman M.J., Vogelbaum M.A., Haque S.J. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Cancer Res. 62:2002;1103-1109.
31. Rando T.A., Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1994;1275-1287.
32. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family. regulation and function Annu. Rev. Immunol. 15:1997;707-747.
33. Rau A., Buttgereit D., Holz A., Fetter R., Doberstein S.K., Paululat A., Staudt N., Skeath J., Michelson A.M., Renkawitz-Pohl R. rolling pebbles (rols) is required in Drosophila muscle precursors for recruitment of myoblasts for fusion. Development. 128:2001;5061-5073.
34. Rengarajan J., Tang B., Glimcher L.H. NFATc2 and NFATc3 regulate T(H)2 differentiation and modulate TCR-responsiveness of naive T(H)cells. Nat. Immunol. 3:2002;48-54.
35. Rommel C., Bodine S.C., Clarke B.A., Rossman R., Nunez L., Stitt T.N., Yancopoulos G.D., Glass D.J. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3:2001;1009-1013.
36. Rosen G.D., Sanes J.R., LaChance R., Cunningham J.M., Roman J., Dean D.C. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell. 69:1992;1107-1119.
37. Rosenblatt J.D., Parry D.J. Gamma irradiation prevents compensatory hypertrophy of overloaded mouse extensor digitorum longus muscle. J. Appl. Physiol. 73:1992;2538-2543.
38. Schleimer R.P., Sterbinsky S.A., Kaiser J., Bickel C.A., Klunk D.A., Tomioka K., Newman W., Luscinskas F.W., Gimbrone M.A. Jr., McIntyre B.W.et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J. Immunol. 148:1992;1086-1092.
39. Taylor M.V. Muscle differentiation. how two cells become one Curr. Biol. 12:2002;R224-R228.
40. Wakelam M.J. The fusion of myoblasts. Biochem. J. 228:1985;1-12.
41. Wunschmann S., Stapleton J.T. Fluorescence-based quantitative methods for detecting human immunodeficiency virus type 1-induced syncytia. J. Clin. Microbiol. 38:2000;3055-3060.
42. Yagami-Hiromasa T., Sato T., Kurisaki T., Kamijo K., Nabeshima Y., Fujisawa-Sehara A. A metalloprotease-disintegrin participating in myoblast fusion. Nature. 377:1995;652-656.
43. Yeoh G.C., Holtzer H. The effect of cell density, conditioned medium and cytosine arabinoside on myogenesis in primary and secondary cultures. Exp. Cell Res. 104:1977;63-78.
44. Zhang M., McLennan I.S. During secondary myotube formation, primary myotubes preferentially absorb new nuclei at their ends. Dev. Dyn. 204:1995;168-177.